Adenosine and ATP receptors, and other members of the signaling pathway, such as AMP-activated protein kinase (AMPK), are involved in obesity, type 2 diabetes (T2D) and OA progression. This evidence concerns the gene P2RX2 and obesity due to melanocortin 4 receptor deficiency.